Genome profiles in maternal blood during early onset preeclampsia and towards term

Journal of Perinatal Medicine

Volumn 38, Issue 6, 2010, Pages 601-608

  Dahlstrøm, Berit ^a   Esbensen, Ying ^a   Vollan, Hilde ^a   Øian, Pål ^b   Bukholm, Geir ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Immune response; Microarray; Preeclampsia; Pregnancy; RNA

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; GENOMIC RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADULT; ARTICLE; AXIS; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MICROARRAY ANALYSIS; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERFERON-GAMMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, CCR3; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; YOUNG ADULT;

EID: 78650100670     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.095     Document Type: Article

References (36)

1. Atalar K, Afzali B, Lord G, Lombardi G. Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transplant. 2009;14:23-9.
2. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86:2505-12. (Pubitemid 32545699)
3. Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol. 2005;35:3054-63. (Pubitemid 41555101)
4. Brzezinska AA, Johnson JL, Munafo DB, Crozat K, Beutler B, Kiosses WB, et al. The Rab27a effectors JFC1/Slp1 and Munc13-4 regulate exocytosis of neutrophil granules. Traffic. 2008;9:2151-64.
5. Cunningham DS, Evans EE. The effects of betamethasone on maternal cellular resistance to infection. Am J Obstet Gynecol. 1991;165:610-5.
6. Dondrup M, Huser AT, Mertens D, Goesmann A. An evaluation framework for statistical tests on microarray data. J Biotechnol. 2009;140:18-26.
7. Du P, Kibbe WA, Lin SM. Iumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008;24:1547-8. (Pubitemid 351911712)
8. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178:5949-56. (Pubitemid 46674392)
9. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001;185:792-7. (Pubitemid 32980513)
10. Gidskehaug L, Anderssen E, Flatberg A, Alsberg BK. A framework for significance analysis of gene expression data using dimension reduction methods. BMC Bioinformatics. 2007;8:346.
11. Hunt JS. Stranger in a strange land. Immunol Rev. 2006;213:36-47. (Pubitemid 44401492)
12. Koch CA, Platt JL. Natural mechanisms for evading graft rejection: the fetus as an allograft. Springer Semin Immunopathol. 2003;25:95-117. (Pubitemid 37130009)
13. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glio-blastoma multiforme. Brain Res. 2009;1286:13-8.
14. Lin D, Shkedy Z, Burzykowski T, Ion R, Gohlmann HW, Bondt AD, et al. An investigation on performance of significance analysis of microarray (SAM) for the comparisons of several treatments with one control in the presence of smallvariance genes. Biom J. 2008;50:801-23.
15. Luppi P, DeLoia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol. 2006;118:268-75. (Pubitemid 43199666)
16. Nightingale TD, Pattni K, Hume AN, Seabra MC, Cutler DF. Rab27a and MyRIP regulate the amount and multimeric state of VWF released from endothelial cells. Blood. 2009;113:5010-8.
17. Okazaki S, Sekizawa A, Purwosunu Y, Farina A, Wibowo N, Okai T. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. Obstet Gynecol. 2007;110:1130-6. (Pubitemid 350059420)
18. Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9q T lymphocytes. J Immunol. 2005;174:4985-90.
19. Pihur V, Datta S, Datta S. Reconstruction of genetic association networks from microarray data: a partial least squares approach. Bioinformatics. 2008;24:561-8. (Pubitemid 351256301)
20. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta. 2003;24: S21-7. (Pubitemid 37184731)
21. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-4. (Pubitemid 40807500)
22. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(Suppl A): S38-42.
23. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3: CD004454.
24. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005;203:38-47.
25. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003;59:161-73. (Pubitemid 36945234)
26. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999;117:550-5. (Pubitemid 29398304)
27. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006;13:680-6. (Pubitemid 44760892)
28. Sargent IL, Borzychowski AM, Redman CW. NK cells and pre-eclampsia. J Reprod Immunol. 2007;76:40-4. (Pubitemid 350100876)
29. Stavrum AK, Petersen K, Jonassen I, Dysvik B. Analysis of gene-expression data using J-Express. Curr Protoc Bioinformatics. 2008; Chapter 7:Unit 7.3.
30. Sun CJ, Zhang L, Zhang WY. Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers. J Perinat Med. 2009;37:609-16.
31. Suriano AR, Sanford AN, Kim N, Oh M, Kennedy S, Henderson MJ, et al. GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol. 2005;25:9073-81. (Pubitemid 41429095)
32. Syrbe U, Siveke J, Hamann A. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol. 1999;21:263-85. (Pubitemid 30011439)
33. Tau GZ, von der WT, Lu B, Cowan S, Kvatyuk M, Pernis A, et al. Interferon gamma signaling alters the function of T helper type 1 cells. J Exp Med. 2000;192:977-86.
34. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-21. (Pubitemid 32397092)
35. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? Br J Obstet Gynaec. 2004;111:298-302. (Pubitemid 38446102)
36. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143-8. (Pubitemid 37521365)